TelyRx Holdings Inc. is making waves on the TSX with a remarkable 6.22% surge in just one trading day.
In a notable performance on the Toronto Stock Exchange, TelyRx Holdings Inc. (TELY.TO) saw its stock price climb by 6.22%, closing at CA$2.56. This uptick comes amidst a backdrop of recent financial announcements and strategic moves that could signal a positive shift for the company.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$73.09M
52W high
$4.25
52W low
$2.00
1W change
+10.20%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 122.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+122.2% Upside
Current Price
C$2.70
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
102.6%
Annualized
90-Day Vol
97.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.26
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.54 | C$1.79 โ C$3.62 |
| 60 trading days | C$2.40 | C$1.45 โ C$3.95 |
| 90 trading days | C$2.26 | C$1.22 โ C$4.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the implications of TelyRx's recent financial results and market activities, as they may indicate a growing momentum in the company's operations.
6.22% Surge in One Day
TelyRx's stock has risen to CA$2.56, marking a significant increase that could attract further investor interest.
Bull case
The recent rise in TelyRx's stock price reflects investor optimism after the company reported impressive revenue growth in its latest financial results. This suggests that TelyRx may be on the path to profitability.
Bear case
Despite the positive stock movement, TelyRx still faces challenges. The company reported a net loss in its latest earnings, raising concerns about its long-term sustainability.
A Closer Look at TelyRx's Financial Performance
TelyRx recently announced its first quarter financial results, showcasing a significant revenue jump to CA$19.4 million, up from CA$6.9 million year-over-year. Despite a net loss of CA$4.7 million, the revenue growth has sparked investor interest and optimism about the company's future.
Market Reactions and Future Outlook
The stock's impressive rise can be attributed to a combination of strategic moves, including the completion of a reverse takeover and the start of trading on the TSX. Investors are keenly watching to see if this momentum can be sustained in the coming quarters.
Understanding the Risks Ahead
While the stock's performance is encouraging, potential investors should remain cautious. TelyRx's ongoing net losses highlight the need for continued growth and operational efficiency to ensure long-term viability in a competitive market.
Advertisement
